Standout Papers

Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an i... 2017 2026 2020 2023 336
  1. Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical t (2017)
    Marjolein de Bruin‐Weller, Diamant Thaçi et al. British Journal of Dermatology

Immediate Impact

85 standout
Sub-graph 1 of 21

Citing Papers

Current insights and future perspectives of ultraviolet radiation (UV) exposure: Friends and foes to the skin and beyond the skin
2024 Standout
Macrophage polarization: an important role in inflammatory diseases
2024 Standout
2 intermediate papers

Works of Z. Chen being referenced

Laboratory safety of dupilumab in moderate-to-severe atopic dermatitis: results from three phase III trials (LIBERTY AD SOLO 1, LIBERTY AD SOLO 2, LIBERTY AD CHRONOS)
2019
Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical t
2017 Standout
and 1 more

Author Peers

Author Last Decade Papers Cites
Z. Chen 666 318 538 20 725
Louise A. A. Gerbens 525 254 438 35 600
Daphne S. Bakker 599 243 442 33 665
M.E. Schram 695 283 602 16 788
Ryosuke Mihara 692 311 480 21 828
Margeaux Oliva 493 202 321 17 637
Natalija Novak 626 299 582 21 847
Suzanne J. Tintle 578 213 376 19 796
Jorien van der Schaft 517 238 399 23 669
Y.M.F. Andersen 664 270 418 32 829
Helen Nankervis 478 229 420 21 581

All Works

Loading papers...

Rankless by CCL
2026